Dorsal root ganglia sensory neuronal cultures: A tool for drug discovery for peripheral neuropathies

Expert Opinion on Drug Discovery

Volumn 4, Issue 10, 2009, Pages 1035-1045

  Melli, Giorgia ^a   Höke, Ahmet ^b  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dorsal root ganglion; Neuroprotection; Phenotypic screen; Sensory neuron

Indexed keywords

CISPLATIN; NOCICEPTIN; PACLITAXEL; RECOMBINANT ERYTHROPOIETIN; THIOCTIC ACID;

CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; DEMYELINATING NEUROPATHY; DIABETIC NEUROPATHY; DISEASE ASSOCIATION; DISEASE MODEL; DRUG SCREENING; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VIVO CULTURE; MYELINATED NERVE; NERVE CELL CULTURE; NERVE FIBER DEGENERATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OUTCOME ASSESSMENT; PATHOGENESIS; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; REVIEW; SCHWANN CELL; SENSORY NERVE; SPINAL GANGLION;

EID: 70349408772     PISSN: 17460441     EISSN: None     Source Type: Journal    
DOI: 10.1517/17460440903266829     Document Type: Review

References (71)

1. Wood PM, Bunge RP. Myelination of cultured dorsal root ganglion neurons by oligodendrocytes obtained from adult rats. J Neurol Sci 1986;74(2-3):153-169
2. Horie H, Kim SU. Improved survival and differentiation of newborn and adult mouse neurons in F12 defined medium by fibronectin. Brain Res 1984;294(1):178-181 (Pubitemid 14159296)
3. Scott BS. Adult mouse dorsal root ganglia neurons in cell culture. J Neurobiol 1977;8(5):417-427
4. Eldridge CF, Bunge MB, Bunge RP, et al. Differentiation of axon-related Schwann cells in vitro. I. Ascorbic acid regulates basal lamina assembly and myelin formation. J Cell Biol 1987;105(2):1023-1034
5. Keswani SC, Chander B, Hasan C, et al. FK506 is neuroprotective in a model of antiretroviral toxic neuropathy. Ann Neurol 2003;53(1):57-64 (Pubitemid 36083829)
6. Melli G, Jack C, Lambrinos GL, et al. Erythropoietin protects sensory axons against paclitaxel-induced distal degeneration. Neurobiol Dis 2006;24(3):525-530 (Pubitemid 44716681)
7. Melli G, Taiana M, Camozzi F, et al. Alpha-lipoic acid prevents mitochondrial damage and neurotoxicity in experimental chemotherapy neuropathy. Exp Neurol 2008;214(2):276-284
8. Vincent AM, Russell JW, Sullivan KA, et al. SOD2 protects neurons from injury in cell culture and animal models of diabetic neuropathy. Exp Neurol 2007;208(2):216-227
9. Campenot RB. Local control of neurite development by nerve growth factor. Proc Natl Acad Sci USA 1977;74(10):4516-4519
10. Melli G, Keswani SC, Fischer A, et al. Spatially distinct and functionally independent mechanisms of axonal degeneration in a model of HIV-associated sensory neuropathy. Brain 2006;129(Pt 5):1330-1338
11. Silva A, Wang Q, Wang M, et al. Evidence for direct axonal toxicity in vincristine neuropathy. J Peripher Nerv Syst 2006;11(3):211-216 (Pubitemid 44286071)
12. Nguyen T, Mehta NR, Conant K, et al. Axonal protective effects of the myelin-associated glycoprotein. J Neurosci 2009;29(3):630-637
13. Yu C, Rouen S, Dobrowsky RT. Hyperglycemia and downregulation of caveolin-1 enhance neuregulin-induced demyelination. Glia 2008;56(8):877-887
14. Oh SB, Tran PB, Gillard SE, et al. Chemokines and glycoprotein120 produce pain hypersensitivity by directly exciting primary nociceptive neurons. J Neurosci 2001;21(14):5027-5035
15. Li F, Obrosova IG, Abatan O, et al. Taurine replacement attenuates hyperalgesia and abnormal calcium signaling in sensory neurons of STZ-D rats. Am J Physiol Endocrinol Metab 2005;288(1):E29-36 (Pubitemid 40023787)
16. Price SA, Gardiner NJ, Duran-Jimenez B, et al. Thioredoxin interacting protein is increased in sensory neurons in experimental diabetes. Brain Res 2006;1116(1):206-214 (Pubitemid 44488597)
17. Estanislao L, Carter K, McArthur J, et al. A randomized controlled trial of 5% lidocaine gel for HIV-associated distal symmetric polyneuropathy. J Acquir Immune Defic Syndr 2004;37(5):1584-1586 (Pubitemid 39658198)
18. Pardo CA, McArthur JC, Griffin JW. HIV neuropathy: insights in the pathology of HIV peripheral nerve disease. J Peripher Nerv Syst 2001;6(1):21-27
19. Keswani SC, Polley M, Pardo CA, et al. Schwann cell chemokine receptors mediate HIV-1 gp120 toxicity to sensory neurons. Ann Neurol 2003;54(3):287-296 (Pubitemid 37072031)
20. Hoke A. Neuroprotection in the peripheral nervous system: rationale for more effective therapies. Arch Neurol 2006;63(12):1681-1685 (Pubitemid 44925074)
21. Keswani SC, Buldanlioglu U, Fischer A, et al. A novel endogenous erythropoietin mediated pathway prevents axonal degeneration. Ann Neurol 2004;56(6):815-826 (Pubitemid 39578445)
22. Bodner A, Toth PT, Miller RJ. Activation of c-Jun N-terminal kinase mediates gp120IIIB- and nucleoside analogue-induced sensory neuron toxicity. Exp Neurol 2004;188(2):246-253 (Pubitemid 38891585)
23. Quasthoff S, Hartung HP. Chemotherapy-induced peripheral neuropathy. J Neurol 2002;249(1):9-17
24. Windebank AJ, Grisold W. Chemotherapy-induced neuropathy. J Peripher Nerv Syst 2008;13(1):27-46
25. Albers J, Chaudhry V, Cavaletti G, et al. Interventions for preventing neuropathy caused by cisplatin and related compounds. Cochrane Database Syst Rev 2007;(1):CD005228
26. Lipton RB, Apfel SC, Dutcher JP, et al. Taxol produces a predominantly sensory neuropathy. Neurology 1989;39(3):368-373
27. Chaudhry V, Rowinsky EK, Sartorius SE, et al. Peripheral neuropathy from taxol and cisplatin combination chemotherapy: clinical and electrophysiological studies. Ann Neurol 1994;35(3):304-311 (Pubitemid 24089653)
28. Peltier AC, Russell JW. Recent advances in drug-induced neuropathies. Curr Opin Neurol 2002;15(5):633-638
29. McDonald ES, Windebank AJ. Cisplatin-induced apoptosis of DRG neurons involves bax redistribution and cytochrome c release but not fas receptor signaling. Neurobiol Dis 2002;9(2):220-233
30. Flatters SJ, Xiao WH, Bennett GJ. Acetyl-L-carnitine prevents and reduces paclitaxel-induced painful peripheral neuropathy. Neurosci Lett 2006;397(3):219-223
31. Jin HW, Flatters SJ, Xiao WH, et al. Prevention of paclitaxel-evoked painful peripheral neuropathy by acetyl-L-carnitine: effects on axonal mitochondria, sensory nerve fiber terminal arbors, and cutaneous Langerhans cells. Exp Neurol 2008;210(1):229-237
32. Leinninger GM, Edwards JL, Lipshaw MJ, et al. Mechanisms of disease: mitochondria as new therapeutic targets in diabetic neuropathy. Nat Clin Pract Neurol 2006;2(11):620-628 (Pubitemid 44614088)
33. Vinik AI, Holland MT, Le Beau JM, et al. Diabetic neuropathies. Diabetes Care 1992;15(12):1926-1975
34. Sumner CJ, Sheth S, Griffin JW, et al. The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology 2003;60(1):108-111 (Pubitemid 36070653)
35. Sima AA, Kamiya H. Diabetic neuropathy differs in type 1 and type 2 diabetes. Ann NY Acad Sci 2006;1084:235-249 (Pubitemid 47091939)
36. Sango K, Saito H, Takano M, et al. Cultured adult animal neurons and schwann cells give us new insights into diabetic neuropathy. Curr Diabetes Rev 2006;2(2):169-183 (Pubitemid 44082938)
37. Sotelo JR, Horie H, Ito S, et al. An in vitro model to study diabetic neuropathy. Neurosci Lett 1991;129(1):91-94
38. Sango K, Horie H, Saito H, et al. Diabetes is not a potent inducer of neuronal cell death in mouse sensory ganglia, but it enhances neurite regeneration in vitro. Life Sci 2002;71(20):2351-2368 (Pubitemid 35264610)
39. Ristic H, Srinivasan S, Hall KE, et al. Serum from diabetic BB/W rats enhances calcium currents in primary sensory neurons. J Neurophysiol 1998;80(3):1236-1244 (Pubitemid 28495723)
40. Srinivasan S, Stevens MJ, Sheng H, et al. Serum from patients with type 2 diabetes with neuropathy induces complement-independent, calcium-dependent apoptosis in cultured neuronal cells. J Clin Invest 1998;102(7):1454-1462 (Pubitemid 28467574)
41. Sango K, Horie H, Okamura A, et al. Diabetes impairs DRG neuronal attachment to extracellular matrix proteins in vitro. Brain Res Bull 1995;37(5):533-537
42. Luo ZJ, King RH, Lewin J, et al. Effects of nonenzymatic glycosylation of extracellular matrix components on cell survival and sensory neurite extension in cell culture. J Neurol 2002;249(4):424-431 (Pubitemid 34304616)
43. Sango K, Verdes JM, Hikawa N, et al. Nerve growth factor (NGF) restores depletions of calcitonin gene-related peptide and substance P in sensory neurons from diabetic mice in vitro. J Neurol Sci 1994;126(1):1-5 (Pubitemid 24305252)
44. Meldolesi J. Rapidly exchanging Ca2+ stores in neurons: molecular, structural and functional properties. Prog Neurobiol 2001;65(3):309-338 (Pubitemid 32709988)
45. Verkhratsky A, Fernyhough P. Mitochondrial malfunction and Ca2+ dyshomeostasis drive neuronal pathology in diabetes. Cell Calcium 2008;44(1):112-122
46. Huang TJ, Price SA, Chilton L, et al. Insulin prevents depolarization of the mitochondrial inner membrane in sensory neurons of type 1 diabetic rats in the presence of sustained hyperglycemia. Diabetes 2003;52(8):2129-2136 (Pubitemid 36919808)
47. Srinivasan S, Stevens M, Wiley JW. Diabetic peripheral neuropathy: evidence for apoptosis and associated mitochondrial dysfunction. Diabetes 2000;49(11):1932-1938 (Pubitemid 30812928)
48. Hong S, Wiley JW. Early painful diabetic neuropathy is associated with differential changes in the expression and function of vanilloid receptor 1. J Biol Chem 2005;280(1):618-627 (Pubitemid 40165028)
49. Russell JW, Golovoy D, Vincent AM, et al. High glucose-induced oxidative stress and mitochondrial dysfunction in neurons. FASEB J 2002;16(13):1738-1748 (Pubitemid 35340354)
50. Vincent AM, McLean LL, Backus C, et al. Short-term hyperglycemia produces oxidative damage and apoptosis in neurons. FASEB J 2005;19(6):638-640 (Pubitemid 40471270)
51. Vincent AM, Stevens MJ, Backus C, et al. Cell culture modeling to test therapies against hyperglycemia-mediated oxidative stress and injury. Antioxid Redox Signal 2005;7(11-12):1494-1506 (Pubitemid 41767985)
52. Vincent AM, Feldman EL. Can drug screening lead to candidate therapies for testing in diabetic neuropathy? Antioxid Redox Signal 2008;10(2):387-393
53. Walsh GS, Orike N, Kaplan DR, et al. The invulnerability of adult neurons: a critical role for p73. J Neurosci 2004;24(43):9638-9647 (Pubitemid 39441518)
54. Tomlinson DR, Gardiner NJ. Diabetic neuropathies: components of etiology. J Peripher Nerv Syst 2008;13(2):112-121
55. Price SA, Hounsom L, Purves-Tyson TD, et al. Activation of JNK in sensory neurons protects against sensory neuron cell death in diabetes and on exposure to glucose/ oxidative stress in vitro. Ann NY Acad Sci 2003;1010:95-99 (Pubitemid 38268114)
56. Gumy LF, Bampton ET, Tolkovsky AM. Hyperglycaemia inhibits Schwann cell proliferation and migration and restricts regeneration of axons and Schwann cells from adult murine DRG. Mol Cell Neurosci 2008;37(2):298-311
57. Purves T, Middlemas A, Agthong S, et al. A role for mitogen-activated protein kinases in the etiology of diabetic neuropathy. FASEB J 2001;15(13):2508-2514 (Pubitemid 33063180)
58. Zherebitskaya E, Akude E, Smith DR, et al. Development of selective axonopathy in adult sensory neurons isolated from diabetic rats: role of glucose-induced oxidative stress. Diabetes 2009;58(6):1356-1364
59. Cheng C, Zochodne DW. Sensory neurons with activated caspase-3 survive long-term experimental diabetes. Diabetes 2003;52(9):2363-2371 (Pubitemid 37059508)
60. Kamiya H, Zhang W, Sima AA. Degeneration of the Golgi and neuronal loss in dorsal root ganglia in diabetic BioBreeding/Worcester rats. Diabetologia 2006;49(11):2763-2774
61. Kennedy JM, Zochodne DW. Impaired peripheral nerve regeneration in diabetes mellitus. J Peripher Nerv Syst 2005;10(2):144-157 (Pubitemid 40984889)
62. Sereda M, Griffiths I, Puhlhofer A, et al. A transgenic rat model of Charcot-Marie-Tooth disease. Neuron 1996;16(5):1049-1060 (Pubitemid 26171699)
63. Nobbio L, Mancardi G, Grandis M, et al. PMP22 transgenic dorsal root ganglia cultures show myelin abnormalities similar to those of human CMT1A. Ann Neurol 2001;50(1):47-55
64. Nobbio L, Vigo T, Abbruzzese M, et al. Impairment of PMP22 transgenic Schwann cells differentiation in culture: implications for Charcot-Marie-Tooth type 1A disease. Neurobiol Dis 2004;16(1):263-273 (Pubitemid 38569816)
65. Nobbio L, Gherardi G, Vigo T, et al. Axonal damage and demyelination in long-term dorsal root ganglia cultures from a rat model of Charcot-Marie-Tooth type 1A disease. Eur J Neurosci 2006;23(6):1445-1452
66. Lehmann HC, Kohne A, Meyer zu Horste G, et al. Role of nitric oxide as mediator of nerve injury in inflammatory neuropathies. J Neuropathol Exp Neurol 2007;66(4):305-312
67. Acosta C, Davies A. Bacterial lipopolysaccharide regulates nociceptin expression in sensory neurons. J Neurosci Res 2008;86(5):1077-1086
68. Raymon HK, Thode S, Zhou J, et al. Immortalized human dorsal root ganglion cells differentiate into neurons with nociceptive properties. J Neurosci 1999;19(13):5420-5428 (Pubitemid 29300207)
69. Chen W, Mi R, Haughey N, et al. Immortalization and characterization of a nociceptive dorsal root ganglion sensory neuronal line. J Peripher Nerv Syst 2007;12(2):121-130 (Pubitemid 46906334)
70. Durr O, Duval F, Nichols A, et al. Robust hit identification by quality assurance and multivariate data analysis of a high-content, cell-based assay. J Biomol Screen 2007;12(8):1042-1049 (Pubitemid 350179703)
71. Narro ML, Yang F, Kraft R, et al. NeuronMetrics: software for semi-automated processing of cultured neuron images. Brain Res 2007;1138:57-75 (Pubitemid 46298976)